News for Providers
Top stories summarized by our editors
3/30/2020

Play promotes creativity in children, which benefits development and mental health, writes social worker Ashley Nestler. She provides examples of how parents can affirm children's creativity and activities that will keep them engaged and busy, especially with the increased isolation caused by the coronavirus pandemic.

Full Story:
Thrive Global
3/30/2020

The Trump administration promises to get a loan program for small businesses up and running by Friday, aiming to prevent companies from going out of business or laying off workers. Companies with fewer than 500 employees can seek as much as $10 million to pay expenses, including wages and rent, for two months.

Full Story:
MarketWatch
3/30/2020

Control your frustrations by learning how to pause and process while giving people space to vent without adding your emotional fuel, writes Lolly Daskal. "Controlling your emotions is a big part of the emotional intelligence needed for great leadership, especially in times of change and challenge," she writes.

Full Story:
Lolly Daskal
3/30/2020

A study published in Circulation found that patients who took both aspirin and rivaroxaban twice a day had a consistent and similar relative risk reduction for cardiovascular death, myocardial infarction or stroke in patients with and without diabetes, compared with those who took placebo and aspirin. Based on data from 18,278 patients, the findings also revealed that those with diabetes had greater absolute risk reductions with rivaroxaban for the primary efficacy endpoint at three years and for all-cause mortality, compared with those without the disease.

More Summaries:
rivaroxaban
3/30/2020

A study involving 70 patients with chronic kidney disease and diabetes found that 64% of those who took veverimer had at least a 4 mEq/L increase or normalization of serum bicarbonate, compared with 38% of those on placebo, indicating veverimer as a better option for treating metabolic acidosis. The findings, presented at the virtual National Kidney Foundation meeting, also revealed that those who took veverimer experienced a 12.5-point improvement in physical functioning, compared with +0.3 for those who took placebo.

More Summaries:
veverimer
3/30/2020

Johnson & Johnson officials on Monday said plans call for beginning human testing of its experimental vaccine for the novel coronavirus by September, and it could be ready for emergency use authorization by early next year. J&J pledged more than $1 billion to a partnership with HHS' Biomedical Advanced Research and Development Authority for vaccine research.

Full Story:
CNBC
3/30/2020

More than $100 billion for health care organizations is included in the $2 trillion Coronavirus Aid, Relief and Economic Security Act signed into law Friday, but PYA's consulting practice said health care providers should look into three specific programs first. The Paycheck Protection Program, the Public Health and Social Services Emergency Fund, and Medicare provisions can have an immediate financial effect.

Full Story:
HealthLeaders Media
More Summaries:
PYA
3/30/2020

The FDA granted emergency use authorization to Abbott's ID NOW COVID-19 test, which can deliver positive results in five minutes and negative results in 13. The portable test is small enough that it can be used in most health care settings, and Abbott said it expects to manufacture about 5 million tests per month and deliver 50,000 tests per day starting this week.

Full Story:
Business Insider, The Hill
3/30/2020

Artificial intelligence researchers and developers have argued that the technology could be used to study chest images and detect COVID-19, the illness caused by the novel coronavirus, thus assisting in diagnostic testing. But several radiology groups, including the ACR, don't support using chest scans for first-line diagnosis, regardless of AI involvement, because of potential study design flaws and exposure risk. Radiologist Ella Kazerooni says it isn't clear if AI can distinguish COVID-19 from other illnesses of the lower-respiratory system, adding that "when you're just comparing normal and abnormal scans ... it's not very helpful."

3/30/2020

The ACR expressed support for the approval of the $2 trillion Coronavirus Aid, Relief, and Economic Security Act, which will also offer $100 billion for health providers affected by the ongoing coronavirus pandemic, and is awaiting "swift regulatory action" detailing how imaging providers can secure relief. "We also intend to encourage the Congress to revisit any shortfalls that may exist in the current legislation, as we expect another COVID economic stimulus bill to be developed in the coming weeks," said Cynthia Moran, executive vice president of government relations and health policy for the ACR.

Full Story:
Radiology Business